[Form 4] Tivic Health Systems, Inc. Insider Trading Activity
Jennifer Ernst, who serves as Chief Executive Officer and a director of Tivic Health Systems, Inc. (TIVC), received a grant of 85,000 employee stock options with an exercise price of $3.32. The options vest 50% on the first anniversary of the grant and the remaining 50% in twelve equal quarterly installments, so the award is fully vested by the fourth anniversary. The grant is held directly and the instrument lists an expiration date of 08/05/2035, providing roughly a ten-year term to exercise. This filing reports the occurrence and material vesting terms of the award but does not disclose market-price context, tax treatment, or any performance-based conditions.
Jennifer Ernst, che ricopre la carica di amministratrice delegata e membro del consiglio di amministrazione di Tivic Health Systems, Inc. (TIVC), ha ricevuto una concessione di 85,000 stock option per dipendenti con un prezzo di esercizio di $3.32. Le opzioni maturano per il 50% al primo anniversario della concessione e per il restante 50% in dodici rate trimestrali uguali, cos矛 l'assegnazione 猫 completamente maturata entro il quarto anniversario. La concessione 猫 detenuta direttamente e il documento riporta una data di scadenza del 08/05/2035, offrendo circa un termine di dieci anni per l'esercizio. Questa comunicazione segnala l'avvenuta assegnazione e i termini sostanziali di maturazione dell'incentivo, ma non fornisce il contesto del prezzo di mercato, il trattamento fiscale o eventuali condizioni basate sulle prestazioni.
Jennifer Ernst, que ejerce como directora ejecutiva y miembro del consejo de administraci贸n de Tivic Health Systems, Inc. (TIVC), recibi贸 una concesi贸n de 85,000 opciones sobre acciones para empleados con un precio de ejercicio de $3.32. Las opciones se consolidan al 50% en el primer aniversario de la concesi贸n y el 50% restante en doce pagos trimestrales iguales, por lo que la adjudicaci贸n queda totalmente consolidada en el cuarto aniversario. La concesi贸n est谩 mantenida directamente y el documento indica una fecha de vencimiento del 08/05/2035, proporcionando aproximadamente un plazo de diez a帽os para su ejercicio. Esta presentaci贸n informa de la concesi贸n y de los t茅rminos materiales de consolidaci贸n, pero no revela el contexto del precio de mercado, el tratamiento fiscal ni condiciones basadas en el rendimiento.
Jennifer Ernst電� Tivic Health Systems, Inc. (TIVC)鞚� 斓滉碃瓴届榿鞛�(CEO) 瓴� 鞚挫偓搿滌劀 85,000欤检潣 膦呾梾鞗� 鞀ろ啞鞓奠厴鞚� 頄夓偓臧�瓴� $3.32搿� 攵�鞐皼鞎橃姷雼堧嫟. 鞓奠厴鞚� 攵�鞐澕搿滊秬韯� 1欤茧厔 鞁� 50%臧� 氩犾姢韺呺悩瓿� 雮橂ǜ歆� 50%電� 12須岇潣 霃欖澕頃� 攵勱赴氤� 攵勴暊搿� 氩犾姢韺呺悩鞏� 雱� 氩堨Ц 旮半厫鞚缄箤歆� 鞕勳爠頌� 氩犾姢韺呺惄雼堧嫟. 頃措嫻 攵�鞐姅 歆侅为 氤挫湢霅橃柎 鞛堨溂氅� 氍胳劀鞐愲姅 毵岆鞚� 08/05/2035臧� 旮办灛霅橃柎 鞛堨柎 頄夓偓 臧�電ロ暅 旮瓣皠鞚� 鞎� 10雲勳瀰雼堧嫟. 鞚� 鞝滌稖靹滊姅 攵�鞐� 氚滌儩瓿� 欤检殧 氩犾姢韺� 臁瓣贝鞚� 氤搓碃頃橃毵� 鞁滌灔臧�瓴� 毵ル澖, 靹鸽 觳橂Μ 霕愲姅 靹标臣 旮半皹 臁瓣贝鞐� 雽�頃挫劀電� 瓿店皽頃橃 鞎婌姷雼堧嫟.
Jennifer Ernst, qui est directrice g茅n茅rale et administratrice de Tivic Health Systems, Inc. (TIVC), a re莽u une attribution de 85,000 options d'achat d'actions pour employ茅s au prix d'exercice de $3.32. Les options acqui猫rent 50% de leurs droits au premier anniversaire de l'attribution et les 50% restants en douze versements trimestriels 茅gaux, de sorte que l'attribution est enti猫rement acquise au quatri猫me anniversaire. L'attribution est d茅tenue directement et l'instrument mentionne une date d'expiration au 08/05/2035, offrant environ un d茅lai d'exercice de dix ans. Ce d茅p么t signale l'octroi et les modalit茅s substantielles d'acquisition, mais ne divulgue pas le contexte du prix du march茅, le traitement fiscal ni d'茅ventuelles conditions li茅es 脿 la performance.
Jennifer Ernst, die als Chief Executive Officer und Direktorin von Tivic Health Systems, Inc. (TIVC) t盲tig ist, erhielt eine Zuteilung von 85.000 Mitarbeiteraktienoptionen mit einem Aus眉bungspreis von $3.32. 50% der Optionen vesten am ersten Jahrestag der Zuteilung und die verbleibenden 50% in zw枚lf gleichen viertelj盲hrlichen Raten, sodass die Zuwendung bis zum vierten Jahrestag vollst盲ndig vestet. Die Zuteilung wird direkt gehalten und im Dokument ist ein Verfallsdatum 08/05/2035 angegeben, was einen ungef盲hren Aus眉bungszeitraum von zehn Jahren ergibt. Diese Meldung berichtet 眉ber das Stattfinden und die wesentlichen Vesting-Bedingungen der Zuteilung, legt jedoch keine Informationen zum Marktpreis, zur steuerlichen Behandlung oder zu leistungsabh盲ngigen Bedingungen offen.
- 85,000-option grant provides direct long-term incentive to the CEO with explicit vesting terms
- Clear vesting schedule: 50% after one year and the remainder in 12 equal quarterly installments, fully vested at four years
- 10-year term indicated by the listed expiration date of 08/05/2035, giving time to realize value
- Potential dilution of 85,000 shares upon exercise is disclosed but company share count or percentage dilution is not provided
- No performance conditions disclosed; vesting is solely time-based, which may not tie pay directly to performance metrics
Insights
TL;DR Time-based option grants to executives are a standard retention tool; this grant aligns long-term pay with shareholder value creation.
The 85,000-option award uses a multi-year, time-based vesting schedule that encourages retention through a four-year horizon, which is common practice in executive compensation. The direct ownership and explicit vesting schedule increase transparency. The filing does not disclose performance conditions or additional service requirements beyond vesting dates, so alignment is purely tenure-based rather than performance-linked. Impact on governance is neutral to modestly positive because the structure supports long-term alignment without introducing complex contingencies.
TL;DR An 85,000-option grant at $3.32 with a ~10-year term is a normal executive equity award; dilution and pay-for-performance details are key to assess materiality.
The grant specifies an exercise price of $3.32 and an expiration date of 08/05/2035, indicating a roughly ten-year option term. Vesting (50% after one year, remainder over 12 quarterly installments) spreads realized exposure over four years. From a compensation accounting and dilution perspective, the immediate issuance increases potential outstanding shares by 85,000 upon exercise; however, the filing provides no information on the company鈥檚 outstanding share count, market price at grant, or any performance hurdles, limiting quantitative assessment of dilution or anticipated expense. Overall investor impact appears routine absent additional context.
Jennifer Ernst, che ricopre la carica di amministratrice delegata e membro del consiglio di amministrazione di Tivic Health Systems, Inc. (TIVC), ha ricevuto una concessione di 85,000 stock option per dipendenti con un prezzo di esercizio di $3.32. Le opzioni maturano per il 50% al primo anniversario della concessione e per il restante 50% in dodici rate trimestrali uguali, cos矛 l'assegnazione 猫 completamente maturata entro il quarto anniversario. La concessione 猫 detenuta direttamente e il documento riporta una data di scadenza del 08/05/2035, offrendo circa un termine di dieci anni per l'esercizio. Questa comunicazione segnala l'avvenuta assegnazione e i termini sostanziali di maturazione dell'incentivo, ma non fornisce il contesto del prezzo di mercato, il trattamento fiscale o eventuali condizioni basate sulle prestazioni.
Jennifer Ernst, que ejerce como directora ejecutiva y miembro del consejo de administraci贸n de Tivic Health Systems, Inc. (TIVC), recibi贸 una concesi贸n de 85,000 opciones sobre acciones para empleados con un precio de ejercicio de $3.32. Las opciones se consolidan al 50% en el primer aniversario de la concesi贸n y el 50% restante en doce pagos trimestrales iguales, por lo que la adjudicaci贸n queda totalmente consolidada en el cuarto aniversario. La concesi贸n est谩 mantenida directamente y el documento indica una fecha de vencimiento del 08/05/2035, proporcionando aproximadamente un plazo de diez a帽os para su ejercicio. Esta presentaci贸n informa de la concesi贸n y de los t茅rminos materiales de consolidaci贸n, pero no revela el contexto del precio de mercado, el tratamiento fiscal ni condiciones basadas en el rendimiento.
Jennifer Ernst電� Tivic Health Systems, Inc. (TIVC)鞚� 斓滉碃瓴届榿鞛�(CEO) 瓴� 鞚挫偓搿滌劀 85,000欤检潣 膦呾梾鞗� 鞀ろ啞鞓奠厴鞚� 頄夓偓臧�瓴� $3.32搿� 攵�鞐皼鞎橃姷雼堧嫟. 鞓奠厴鞚� 攵�鞐澕搿滊秬韯� 1欤茧厔 鞁� 50%臧� 氩犾姢韺呺悩瓿� 雮橂ǜ歆� 50%電� 12須岇潣 霃欖澕頃� 攵勱赴氤� 攵勴暊搿� 氩犾姢韺呺悩鞏� 雱� 氩堨Ц 旮半厫鞚缄箤歆� 鞕勳爠頌� 氩犾姢韺呺惄雼堧嫟. 頃措嫻 攵�鞐姅 歆侅为 氤挫湢霅橃柎 鞛堨溂氅� 氍胳劀鞐愲姅 毵岆鞚� 08/05/2035臧� 旮办灛霅橃柎 鞛堨柎 頄夓偓 臧�電ロ暅 旮瓣皠鞚� 鞎� 10雲勳瀰雼堧嫟. 鞚� 鞝滌稖靹滊姅 攵�鞐� 氚滌儩瓿� 欤检殧 氩犾姢韺� 臁瓣贝鞚� 氤搓碃頃橃毵� 鞁滌灔臧�瓴� 毵ル澖, 靹鸽 觳橂Μ 霕愲姅 靹标臣 旮半皹 臁瓣贝鞐� 雽�頃挫劀電� 瓿店皽頃橃 鞎婌姷雼堧嫟.
Jennifer Ernst, qui est directrice g茅n茅rale et administratrice de Tivic Health Systems, Inc. (TIVC), a re莽u une attribution de 85,000 options d'achat d'actions pour employ茅s au prix d'exercice de $3.32. Les options acqui猫rent 50% de leurs droits au premier anniversaire de l'attribution et les 50% restants en douze versements trimestriels 茅gaux, de sorte que l'attribution est enti猫rement acquise au quatri猫me anniversaire. L'attribution est d茅tenue directement et l'instrument mentionne une date d'expiration au 08/05/2035, offrant environ un d茅lai d'exercice de dix ans. Ce d茅p么t signale l'octroi et les modalit茅s substantielles d'acquisition, mais ne divulgue pas le contexte du prix du march茅, le traitement fiscal ni d'茅ventuelles conditions li茅es 脿 la performance.
Jennifer Ernst, die als Chief Executive Officer und Direktorin von Tivic Health Systems, Inc. (TIVC) t盲tig ist, erhielt eine Zuteilung von 85.000 Mitarbeiteraktienoptionen mit einem Aus眉bungspreis von $3.32. 50% der Optionen vesten am ersten Jahrestag der Zuteilung und die verbleibenden 50% in zw枚lf gleichen viertelj盲hrlichen Raten, sodass die Zuwendung bis zum vierten Jahrestag vollst盲ndig vestet. Die Zuteilung wird direkt gehalten und im Dokument ist ein Verfallsdatum 08/05/2035 angegeben, was einen ungef盲hren Aus眉bungszeitraum von zehn Jahren ergibt. Diese Meldung berichtet 眉ber das Stattfinden und die wesentlichen Vesting-Bedingungen der Zuteilung, legt jedoch keine Informationen zum Marktpreis, zur steuerlichen Behandlung oder zu leistungsabh盲ngigen Bedingungen offen.
FAQ
What did Jennifer Ernst report on the Form 4 for TIVC?
What is the exercise price of the options granted to the TIVC CEO?
How do the options granted to Jennifer Ernst vest?
When do the options expire?
Is the ownership direct or indirect?
